Filing Flows

Filing Flows › SkinHealth Systems (SKIN) › Q2 2026 › vs Q2 2025

SkinHealth Systems (SKIN) Q2 2026 vs Q2 2025 (year over year)

SkinHealth Systems's revenue fell $6.1M (-8%) from $78.2M in Q2 2025 to $72.1M in Q2 2026. The biggest changes: Delivery Systems −$4.1M (-18%); Consumables −$2.0M (-4%).

SkinHealth Systems, Q2 2026: revenue $72.1M (-8% year over year), operating margin 5.0%, net loss $2.7M, operating cash flow $2.7M. The chart draws each line against Q2 2025, the increases inside each band.

SkinHealth Systems: what changed, Q2 2026 vs Q2 2025SkinHealth Systems: what changed, Q2 2026 vs Q2 2025Interest & other, net$26.5MCosts & expenses−$25.8MNet loss$22.4MNet loss absorbed$22.4MWorking capital & other−$18.1MOperating costs−$12.3MFree cash flow (OCF − capex)−$7.3MOperating cash flow−$7.0MCost of revenue−$6.3MGeneral & admin−$4.1M

Margins

Q2 2026Q2 2025Change
Free cash flow margin3.1%12.2%-9.1 pts

Every line

LineQ2 2026Q2 2025Change%
Consumables$53.9M$55.8M−$2.0M-4%
Delivery Systems$18.3M$22.4M−$4.1M-18%
Revenue$72.1M$78.2M−$6.1M-8%
Net loss$2.7M−$19.7M$22.4M—
Costs & expenses$74.8M$101M−$25.8M-26%
Operating costs$68.5M$80.9M−$12.3M-15%
Interest & other, net$5.0M−$21.4M$26.5M—
Income tax$1.2M−$993K$2.2M—
Cost of revenue$22.8M$29.1M−$6.3M-22%
Research & development$1.4M$1.3M$156K+12%
Sales & marketing$21.0M$23.1M−$2.1M-9%
General & admin$23.3M$27.5M−$4.1M-15%
Operating cash sources$6.9M$9.6M−$2.7M-28%
Depreciation & amortization$4.0M$4.3M−$294K-7%
Share-based compensation$2.9M$5.3M−$2.4M-45%
Net loss absorbed$2.7M−$19.7M$22.4M—
Working capital & other$1.6M$19.7M−$18.1M-92%
Operating cash flow$2.7M$9.6M−$7.0M-72%
Free cash flow (OCF − capex)$2.2M$9.6M−$7.3M-77%
Capital expenditures$427K$92K$335K+364%

Questions

How much did SkinHealth Systems's revenue grow year over year in Q2 2026?

SkinHealth Systems's revenue fell $6.1M (-8%) from $78.2M in Q2 2025 to $72.1M in Q2 2026.

What drove SkinHealth Systems's revenue change in Q2 2026?

Delivery Systems −$4.1M (-18%); Consumables −$2.0M (-4%).

Q2 2026 results → · Compare in the interactive Sankey →